Impact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Study of insulin resistance (IR) as a predictor for response to interferon based therapy in patients with chronic HCV

Aetiology of anemia in chronic HCV patients receiving pegylated interferon plus ribavirin

Changes in immunomodulators in relation to interferon therapy in hepatitis c virus infection

Relationship between HCV infection and Insulin resistance in non-obese and non-diabetic patients

Evaluation of post interferon therapy changes in chronic HCV patients : Clinical, Doppler ultrasonography and histopathological study

Impact of serum levels of AFP onresponse to treatment ingenotype 4 chronic HCV patients

Hematological complications of chronic HCV infection and its treatment